PlainRecalls
FDA Drug Moderate Class II Terminated

Zoloft (sertraline HCl) tablets 25 mg* 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., NY, NY, 10017 NDC 0049-4960-30

Reported: January 10, 2018 Initiated: October 20, 2017 #D-0151-2018

Product Description

Zoloft (sertraline HCl) tablets 25 mg* 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., NY, NY, 10017 NDC 0049-4960-30

Reason for Recall

SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent

Details

Recalling Firm
Pfizer Inc.
Units Affected
1972 bottles
Distribution
Nationwide in the USA
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Zoloft (sertraline HCl) tablets 25 mg* 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., NY, NY, 10017 NDC 0049-4960-30. Recalled by Pfizer Inc.. Units affected: 1972 bottles.
Why was this product recalled?
SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent
Which agency issued this recall?
This recall was issued by the FDA Drug on January 10, 2018. Severity: Moderate. Recall number: D-0151-2018.